INVESTER I YARROW BIOSCIENCE MED ENDAVU: Køb Yarrow Bioscience ($YARW) aktier gennem Endavu’s investeringsplatform. Hos Endavu kan du købe og sælge aktier i Yarrow Bioscience, og handle med aktier, fraktionaler, ETF'er og andre finansielle instrumenter. Endavu tilbyder handel uden kurtage på amerikanske aktier. Endavu tilbyder lav kurtage på tværs af aktier. Handl med over 30.000 forskellige aktier og udenfor markedsåbningstider.

Yarrow Bioscience, Inc. is a clinical-stage biotechnology company focused on developing therapies for autoimmune thyroid diseases. Its lead product candidate, YB-101, is a humanized monoclonal antibody designed to target the thyroid-stimulating hormone receptor for conditions such as Graves’ disease and thyroid eye disease. The company concentrates on research and development programs centered on these disorders, aiming to address the underlying disease mechanism rather than only managing symptoms. Yarrow Bioscience participates in the biotechnology and pharmaceutical research market, where it advances biologic drug candidates intended for specialized endocrine and immunology indications. The company is headquartered in New Haven, Connecticut, and operates as a focused drug-development platform with a current emphasis on its thyroid autoimmunity pipeline.